Acta Medica International

REVIEW ARTICLE
Year
: 2020  |  Volume : 7  |  Issue : 1  |  Page : 3--6

Tryptase: A novel prognostic biomarker in chronic myeloid leukemia


Anisha Mathew1, Manisha Naithani1, Uttam Kumar Nath2 
1 Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
2 Department of Medical Oncology Hematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

Correspondence Address:
Dr. Manisha Naithani
Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand
India

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of the Philadelphia chromosome. It is treated with tyrosine kinase inhibitor agents targeted against the breakpoint cluster region-Abelson murine leukemia 1 fusion transcript. Disease risk stratification at diagnosis of chronic-phase (CP) CML is done using Sokal, Hasford, and EUTOS scores which use basophilia as a major component. However, basophil counts can be both variable and inaccurate. The serum tryptase level is being studied as a novel biomarker which represents the total basophil compartment. Tryptase, deriving its name from trypsin-like activity commonly expressed by mast cells, and also by immature basophils of patients suffering from various myeloid and leukemic disorders, has a role in tumor proliferation. Patients with seemingly low-normal levels of basophils and raised tryptase levels progress further in disease despite treatment. There is a recent interest in the role of serum tryptase as a prognostic marker in CML-CP.


How to cite this article:
Mathew A, Naithani M, Nath UK. Tryptase: A novel prognostic biomarker in chronic myeloid leukemia.Acta Med Int 2020;7:3-6


How to cite this URL:
Mathew A, Naithani M, Nath UK. Tryptase: A novel prognostic biomarker in chronic myeloid leukemia. Acta Med Int [serial online] 2020 [cited 2020 Oct 21 ];7:3-6
Available from: https://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2020;volume=7;issue=1;spage=3;epage=6;aulast=Mathew;type=0